Paradigm is not currently recruiting for clinical trials. The two trials listed here have closed, and results will be published via our ASX announcements and on our website.
Phase 2 clinical trial for patients with BMLs and Osteoarthritis
A phase 2b, randomised double blind placebo controlled multicentre study to evaluate the effects of pentosan polysulfate sodium on treating pain in subjects with osteoarthritis of the knee and subchondral bone marrow lesions. Details can be found on the ANZCTR website here.
18 December 2018
Paradigm Biopharma announced that it had met its primary endpoint in its phase 2b randomised double-blind placebo-controlled multi-centre clinical trial. Please see our ASX announcements and the video below for more information.